Tensha Therapeutics Financial Analyst Salary | Comparably
Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
102

Tensha Therapeutics Financial Analyst Salary

The average Tensha Therapeutics Financial Analyst earns an estimated $74,764 annually, which includes an estimated base salary of $69,170 with a $5,594 bonus. Tensha Therapeutics' Financial Analyst compensation is $12,636 less than the US average for a Financial Analyst. Financial Analyst salaries at Tensha Therapeutics can range from $60,000 - $130,000.

The Finance Department at Tensha Therapeutics earns $10,704 more on average than the Admin Department.

Last updated 5 years ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$74,764
Average Compensation
$69,170
avg. base
$5,594
avg. bonus

Financial Analyst Salaries at Tensha Therapeutics

Financial Analysts earn $161 more than Financial Analysts, and $5,286 less than Senior Accountants.

Accounting Manager
$112k*
Business Analyst
$91k*
Senior Accountant
$80k*
Financial Analyst
$75k*
Accountant
$67k*
* estimated salary

Compensation at Tensha Therapeutics by Department

The Finance Department averages $10,704 more than the Admin Department, and $2,864 less than the Operations Department

Operations
$73,029 Avg. total comp.
+$3k
Finance
$70,165 Avg. total comp.
Admin
$59,461 Avg. total comp.
-$11k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to Tensha Therapeutics reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to Tensha Therapeutics reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at Tensha Therapeutics Rate Their Compensation

100% say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Tensha Therapeutics

×
Rate your company